Shareholders of Selecta Biosciences, Inc. (NASDAQ:SELB) will be pleased this week, given that the stock price is up 12% to US$4.32 following its latest second-quarter results. Revenues beat ...
I would never claim to be a beat-matcher with a big Traktor controller rig. Rather, I’m an old school selector, deeply ensconced in old school vinyl, rare CDs, and classic 12″ sides. But I am also ...
Selecta Biosciences Inc. SELB is engaged in developing tolerogenic therapies that selectively mitigate unwanted immune responses. The company’s lead pipeline candidate SEL-212 is a combination of its ...
Selecta Bio's stock price closed at $1.600. It is up 20.300% in the last 3 months and down -7.510% in the last 12 months. Selecta Bio saw 4 positive EPS revisions and 0 negative EPS revisions in the ...
Selecta Bio's stock price closed at $1.090. It is down -4.390% in the last 3 months and down -50.000% in the last 12 months. Selecta Bio saw 2 positive EPS revisions and 0 negative EPS revisions in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results